Cargando…

Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment

Targeted therapies against components of the mitogen-activated protein kinase (MAPK) pathway and immunotherapies, which block immune checkpoints, have shown important clinical benefits in melanoma patients. However, most patients develop resistance, with consequent disease relapse. Therefore, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maresca, Luisa, Stecca, Barbara, Carrassa, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099918/ https://www.ncbi.nlm.nih.gov/pubmed/35563772 http://dx.doi.org/10.3390/cells11091466

Ejemplares similares

Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma
por: Anichini, Giulia, et al.
Publicado: (2023)

The Role of the Hedgehog Pathway in Cholangiocarcinoma
por: Anichini, Giulia, et al.
Publicado: (2021)

Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma
por: Pietrobono, Silvia, et al.
Publicado: (2023)

Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma
por: Comito, Francesca, et al.
Publicado: (2022)

Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors
por: Pietrobono, Silvia, et al.
Publicado: (2018)

The Role of Glycosylation in Melanoma Progression
por: De Vellis, Chiara, et al.
Publicado: (2021)

The promise of DNA damage response inhibitors for the treatment of glioblastoma
por: Majd, Nazanin K, et al.
Publicado: (2021)

Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
por: Montagnani, Valentina, et al.
Publicado: (2015)

Therapeutic Targeting of DNA Damage Response in Cancer
por: Choi, Wonyoung, et al.
Publicado: (2022)

Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
por: Pietrobono, Silvia, et al.
Publicado: (2021)

Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer
por: Catalano, Fabio, et al.
Publicado: (2022)

p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells
por: Pietrobono, Silvia, et al.
Publicado: (2022)

The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches
por: Emanuelli, Monica, et al.
Publicado: (2022)

Radiotherapy for Melanoma: More than DNA Damage
por: Rogers, Susanne J., et al.
Publicado: (2019)

Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma
por: Pietrobono, Silvia, et al.
Publicado: (2021)

DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
por: Gönül Geyik, Öykü, et al.
Publicado: (2022)

Microbeam Radiotherapy—A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma
por: Trappetti, Verdiana, et al.
Publicado: (2021)

Integrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer
por: Ubezio, Paolo, et al.
Publicado: (2016)

Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
por: George, Sally L, et al.
Publicado: (2020)

Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
por: Kiss, Robert Csaba, et al.
Publicado: (2021)

PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?
por: Chan, Wei Yen, et al.
Publicado: (2021)

Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma
por: Ceci, Claudia, et al.
Publicado: (2020)

Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
por: Pardella, Elisa, et al.
Publicado: (2020)

The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
por: Chen, Po-Han, et al.
Publicado: (2020)

Therapeutic Inhibitors against Mutated BRAF and MEK for the Treatment of Metastatic Melanoma
por: Ryu, Sunhyo, et al.
Publicado: (2017)

SOX2 as a novel contributor of oxidative metabolism in melanoma cells
por: Andreucci, Elena, et al.
Publicado: (2018)

DNA Damage Response and Immune Defense
por: Nastasi, Claudia, et al.
Publicado: (2020)

Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
por: Nam, Ah-Rong, et al.
Publicado: (2019)

Novel Biomarkers and Therapeutic Targets for Melanoma
por: Sabag, Noa, et al.
Publicado: (2022)

DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway
por: Bhattacharjee, Sonali, et al.
Publicado: (2017)

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
por: Clark, Curtis A., et al.
Publicado: (2022)

Rho GTPases: Novel Players in the Regulation of the DNA Damage Response?
por: Fritz, Gerhard, et al.
Publicado: (2015)

Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies
por: Minchom, Anna, et al.
Publicado: (2018)

Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents
por: Carlsen, Lindsey, et al.
Publicado: (2021)

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2021)

The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer
por: Bouberhan, Sara, et al.
Publicado: (2023)

MicroRNAs, DNA Damage Response, and Cancer Treatment
por: He, Mingyang, et al.
Publicado: (2016)

UVA Radiation, DNA Damage, and Melanoma
por: Jin, Seung-Gi, et al.
Publicado: (2022)

Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
por: Micevic, Goran, et al.
Publicado: (2017)

DNA Damage and Its Role in Cancer Therapeutics
por: Moon, Jaeyoung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jh7lf3484mqm0o3abf9ois4e8r